Effects of Chronic Oestrogen Replacement on Stress‐Induced Activation of Hypothalamic‐Pituitary‐Adrenal Axis Control Pathways

Journal of Neuroendocrinology - Tập 12 Số 8 - Trang 784-794 - 2000
Christopher V. Dayas1, Yangyang Xu, Kathryn M. Buller, Trevor A. Day
1Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland, Australia. [email protected]

Tóm tắt

AbstractOestrogen replacement therapy reportedly suppresses hypothalamic‐pituitary‐adrenal (HPA) axis responses to an emotional stressor in postmenopausal women. However, most studies in the rat suggest a facilitatory role for oestrogen in the control of HPA axis function. One explanation for this difference may be the regimen of oestrogen replacement: during oestrogen replacement therapy, oestrogen levels are low and constant whereas most animal studies examined the HPA axis response when oestrogen levels are rising. In the present study, we assessed HPA axis stress responses in mature ovariectomized rats after plasma oestrogen levels had been maintained at physiological levels for a prolonged period (25 or 100 pg/ml for 7 days). In the case of both an emotional stressor (noise) and a physical stressor (immune challenge by systemic interleukin‐1β administration), oestrogen replacement suppressed stress‐related Fos‐like immunolabelling, in hypothalamic neuroendocrine cells and plasma adrenocorticotropin hormone responses. From the present data, and past reports, it appears unlikely that these effects of oestrogen are due to a direct action on corticotropin‐releasing factor or oxytocin cells. Therefore, to obtain some indication of oestrogen's possible site(s) of action, Fos‐like immunolabelling was mapped in the amygdala and in brainstem catecholamine groups, which are neuronal populations demonstrating substantial evidence of involvement in the generation of HPA axis stress responses. In the amygdala, oestrogen replacement suppressed central nucleus responses to immune challenge, but not to noise. Amongst catecholamine cells, oestrogen replacement was more effective against responses to noise than immune challenge, suppressing A1 and A2 (noradrenergic) and C2 (adrenergic) responses to noise, but only A1 responses to immune challenge. These data suggest that, as in postmenopausal women on oestrogen replacement therapy, chronic low‐level oestrogen replacement can suppress HPA axis stress responses in the rat. Moreover, oestrogen appears to exert effects at multiple sites within putative HPA axis control pathways, even though most of the relevant neuronal populations do not contain genomic receptors for this gonadal steroid and the pattern of oestrogen action differs for an emotional vs a physical stressor.

Từ khóa


Tài liệu tham khảo

Chae CU, 1997, Postmenopausal hormone replacement therapy and cardiovascular disease, Thromb Haemost, 78, 770, 10.1055/s-0038-1657627

10.1038/nm0498-447

Lindheim SR, 1992, Behavioural stress responses in premenopausal and postmenopausal women and the effects of estrogen, Am J Obstet Gynecol, 167, 1831, 10.1016/0002-9378(92)91783-7

10.1177/107155769400100116

10.1016/S0149-7634(05)80175-7

10.1038/196

10.1677/joe.0.1440311

10.1006/hbeh.1994.1044

10.1210/en.136.9.4073

10.1159/000127162

10.1210/endo-129-5-2503

10.1016/S0029-7844(97)00538-3

10.1007/BF03349013

10.1016/0304-3940(87)90141-8

10.1159/000124487

10.1016/0361-9230(95)00017-8

10.1046/j.1460-9568.1999.00645.x

10.1016/S0306-4522(99)00311-5

10.1016/S0166-2236(96)10069-2

10.1073/pnas.93.6.2359

10.1016/S0079-6123(08)61866-X

Day TA, 1999, Control Mechanisms of Stress and Emotion − Neuroendocrine Based Studies., 211

10.1111/j.1365-2826.1990.tb00852.x

10.1159/000127221

10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6

10.1016/0165-0270(93)90023-K

10.1016/0006-8993(80)90354-6

10.1002/cne.902740107

10.1046/j.1365-2826.1998.00231.x

10.1046/j.1365-2826.1996.05252.x

10.1523/JNEUROSCI.15-12-07979.1995

10.1159/000126741

10.1139/y87-095

10.1210/endo.131.3.1324155

10.1210/endo.139.5.6024

10.1016/0306-4522(95)00186-M

10.1046/j.1365-2826.1997.00659.x

10.1073/pnas.95.6.3281

10.1523/JNEUROSCI.14-02-00897.1994

10.1016/0306-4522(94)90439-1

10.1016/0306-4522(92)90322-S

10.1046/j.1365-2826.1997.00593.x

10.1016/0306-4522(94)00355-9

10.1007/BF00228518

10.1016/0028-3908(86)90248-0

10.1016/0006-8993(91)90912-F

10.1016/S0306-4522(96)00406-X

10.1016/S0006-8993(99)01539-5

10.1038/282859a0

10.1111/j.1365-2826.1991.tb00231.x

10.1111/j.1365-2826.1994.tb00547.x

Thông tin
Thông tin xuất bản

Journal of Neuroendocrinology

Tập 12 Số 8

784-794

Thông tin tác giả